IDEA Pharma and Protodigm Develop and Strengthen Workforce with Completed Business Specialists | Information

LONDON, Sept. 17, 2021 /PRNewswire/ — IDEA Pharma, the main biopharma Path to Market Technique observe, is worked up to announce the appointments of {industry} specialists, Dr. Jonathan Lee, Jeff Waldron, and Sayak ‘Sy’ Mukherjee to their workforce. New workforce members, Dr. Lee and Waldron shall be advising IDEA Pharma in early section path to market methods, whereas Mukherjee will help IDEA and its sister firm, Protodigm, a first-of-its-kind contract life sciences skunkworks firm, providing its shoppers analysis, innovation, and a universe of potentialities through which a drug might be dropped at market.

Sy Mukherjee comes from a pharma {industry} writing background, having labored at Fortune & Biopharma Dive beforehand, with a bachelor’s diploma from Dartmouth. Mukherjee shall be instrumental to helping IDEA Pharma and Protodigm CEO, Mike Rea, launch particular tasks.

“I’m wanting ahead to working with Mike and the groups at IDEA and Protodigm, and assist talk this breakthrough considering,” mentioned Mukherjee, Communications Architect, IDEA Pharma. “Drawing inspiration from my expertise in biotech reporting, I’m eager to convey IDEA and Protodigm’s revolutionary ideas not solely to our shopper tasks, however to the eyes and ears of the Biopharma {industry}.”

Dr. Jonathan Lee most not too long ago accomplished his MBA from the Mentioned Enterprise College in Oxford and earned his doctorate in physiotherapy from the Virginia Commonwealth College in Richmond, VA. He shall be becoming a member of the workforce as a medical technique marketing consultant lending each his medical and enterprise experience to shopper tasks.

“IDEA Pharma is making leaps in modern drug candidate improvement and early positioning. I’m excited to immerse myself on this course of of recent age biotech transformation,” mentioned Dr. Lee, Medical Strategist, IDEA Pharma.

Jeff Waldron has robust company technique {qualifications} with a Wharton MBA in technique and shall be essential to IDEA in managing shopper relationships and implementing enterprise improvement methods. He brings cross-functional {industry} expertise and constructed a worldwide community of healthcare collaborators throughout all silos of the {industry}, together with a large number of pharma corporations.

“In my profession, I’ve been recognized to construct bridges to foster collaboration and scientific development,” mentioned Waldron. “I look ahead to persevering with to convey folks with large concepts collectively and nurture new relationships that can change medication at IDEA Pharma.”

Mike Rea, CEO, IDEA Pharma and Protodigm added, “Our objective is to convey a particular magic to our shopper’s challenges – it is a completely different self-discipline than corporations have been used to. These current hires can harness deep expertise however convey the disciplined creativity that early section has been missing.”

About IDEA Pharma:

Via information, perception, and unusual creativity, we unlock the potential of each molecule, inspiring and empowering the pharma {industry} to ship medicines that make a distinction. We work with shoppers early within the lifecycle, crafting a technique that helps each molecule attain its potential. It is what we do greatest. And there is no person that does it fairly like us. For additional data, please go to our web site or be a part of us on FbLinkedIn, and Twitter.

About Protodigm:

Protodigm is a contract skunkworks firm offering its shoppers an investigational physique to invent and innovate new property. Protodigm applies skunkworks strategies to drug improvement giving its shoppers all doable improvement choices by producing hypotheses and supporting proof. This method breaks the {industry} mildew as a result of drug improvement is just too typically a high-risk, single-track course of. If an asset fails, it may be devastating. With a skunkworks method, property might be developed with a number of parallel choices along with its initially supposed use, de-risking innovation, saving time, cash, and energy.

Study extra about Protodigm at

Media contact:

Charlie Mason

IDEA Pharma

[email protected]

+44 1234 756 340

Scott Stachowiak

Russo Companions LLC

[email protected]

+1 (646) 942-5630

View unique content material:


Previous post Why MLMs Like LuLaRoe Are Disturbingly Just like Cults
Next post Prepare dinner County property tax invoice sends Palatine Kinsch Florist and Backyard Middle out of enterprise, household says